Table 1.
Minimum inhibitory concentration (MIC) of celecoxib against Gram-positive bacteria.
| Bacteria | Description | Celecoxib (μg/ml) |
|---|---|---|
| Methicillin-resistant Staphylococcus aureus ATCC 4330 | Clinical isolate resistant to methicillin and oxacillin | 32 |
| Vancomycin-resistant S. aureus (VRSA10) | Resistant to ciprofloxacin, clindamycin, erythromycin, and gentamicin | 32 |
| Streptococcus pneumoniae ATCC 49619 | Isolated from sputum of 75-year-old male, Phoenix, AZ, USA | 64 |
| Bacillus anthracis | Stern vaccine strain | 16 |
| B. anthracis UM23 | Weybridge strain which contains the toxigenic pXO1 plasmid and lacks the pXO2 capsule plasmid | 16 |
| B. anthracis AMES35 | Isolated from 14-month-old heifer that died in Texas in 1981. It is a derivative of B. anthracis, strain Ames that was treated with novobiocin to cure it of the pXO2 plasmid. | 16 |
| B. subtilis CU 1065 | - | 16 |
| Listeria monocytogenes | F4244 CDC. Clinical isolate from patient cerebrospinal fluid (CSF) | 32 |
| Mycobacterium smegmatis ATCC 14468 | Reference strain | 16 |